1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B46973A370AEF18585257F1D006DCBBE
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/winning-necessary-resources-successful-product-launch
18
19
2018.212.90.230
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Product Launch » Product Launch Excellence

Winning Necessary Resources for a Successful Product Launch

ID: PSM-326


Features:

20 Info Graphics

41 Data Graphics

700+ Metrics

8 Narratives


Pages: 120


Published: 2015


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
The objective of this benchmarking study is to help biopharma leaders develop competitive launch and pre-launch activity budgets to ensure successful U.S. market entry for new products.


This data will serve as a reference or comparison point for brand and marketing leaders as they develop budgets and allocate funds for their new brands.

  • Industry average cost for new pharmaceutical product launch
  • Average cost for multiple specialty, single specialty and primary product launches
  • Percentage of budget allocated to 12  key marketing, education and market access activities during and prior to launch
  • Timing for conducting 50+ activities
  • FTE Allocated to key launch activities
  • Anticipated budget & activity trends
  • Top 3 success factors

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Medical Device; Manufacturing; Consumer Products; Chemical


Companies Profiled:
Abbott; AbbVie; Amgen; Astellas; Baxter; Bayer; Boehringer Ingelheim; Cutanea; Eli Lilly; EMD Serono; Genentech; GlaxoSmithKline; Grunenthal; Inspire; Ipsen; Lundbeck; Nektar; Novartis; Noven; Novo Nordisk; Pharmacyclics; Regeneron; Roche; Sebela; Servier; Shire; Teva; Zydus Cadila


Study Snapshot

Because this is a fast changing, highly competitive industry, pharmaceutical companies can no longer rely on past experiences when budgeting for a new product launch. In order for companies to ensure a successful U.S. market entry, we developed this benchmark.

This report provides exclusive new data on the cost of launching a pharmaceutical product in today’s market. This data will guide brand leaders in the critical budget-planning process to ensure that funding levels are adequate and launch activities are well-prioritized and well-timed over the three years before product launch and during launch year. The study identifies current investment levels needed for marketing programs, educational activities and market-access efforts required to bring a new successful drug to market. The report will also focus on top success factors for successful product launches.

Key Findings

1. Specialty launches have become a focus of companies, as 74% target specialty care physicians only. Medical Affairs plays an increasingly important role: MSLs are central to market education and thought leader engagement. Medical Affairs plays an increasingly important role: MSLs are central to market education and thought leader engagement.

2. Health economics, outcomes and payer education are activities that are of increasing importance earlier & at launch. Medical Affairs plays an increasingly important role: MSLs are central to market education and thought leader engagement.

3. Field based investments, in areas such as samples, launch meetings and sales force preparation are being reduced. Medical Affairs plays an increasingly important role: MSLs are central to market education and thought leader engagement.

4. Medical Affairs plays an increasingly important role: MSLs are central to market education and thought leader engagement.


Table of Contents

Executive Summary    pp. 3-9 
    Research Objectives & Methodology  p. 4
    Universe of Learning  p. 5
    Key Findings  p.6-9
Benchmark Profile  p. 10-13
Launch Investment Benchmarks  p. 14-23
Investment Data by Product Segment  p. 24-52
Launch Activities  p. 53-67
Launch Investment Allocations  p. 68-92
Launch Staffing Allocations  p. 93-108
Success Factors  p. 109-113
Investment Ratios  p. 114-119
About Best Practices, LLC    p. 120